search
Back to results

Fear and Avoidance in PTSD Patients

Primary Purpose

Post Traumatic Stress Disorder

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Fear Conditioning
Avoidance conditioning
Pavlovian fear extinction learning
Willingness to pay to avoid shock
Sponsored by
NYU Langone Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Post Traumatic Stress Disorder

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. 18 - 70 years of age
  2. Female or Male
  3. Inclusion Criteria: PTSD Subjects

    a. Diagnosis of current PTSD (as determined by CAPS, and primary diagnosis of PTSD as determined by SCID assessment of comorbidity)

  4. Inclusion Criteria: Trauma-exposed healthy controls (TEHC)

    1. SCID diagnosis consistent with no current or past history of Axis I psychiatric disorders, and no current or past history of PTSD (as determined by the CAPS).
    2. History of trauma exposure.
  5. Willing and able to provide informed consent.

Exclusion Criteria for ALL subjects:

  1. History of neurologic disease (e.g. tic disorder)
  2. Current suicidal ideation, plan or intent or suicidal behavior in past 6 months based on CSSRS or Self-injurious behavior that involves suicidal intent, requires medical attention, or occurs daily
  3. History of seizure or significant head trauma (i.e., extended loss of consciousness, neurological sequelae, or known structural brain lesion)
  4. History of the following Axis I psychiatric diagnosis: psychotic disorder, bipolar disorder, current eating disorder, or current or early remission substance abuse disorder.
  5. Use of psychotropic medication within 4 weeks prior to study (within 6 weeks for fluoxetine, or other long-lived compounds; within one year for neuroleptics).
  6. Current substance use (assessed by urine toxicology; positive urine toxicology screen for any substance, with the exception of THC).
  7. Pregnancy (to be ruled out by urine ß-HCG).
  8. Metallic implants or devices contraindicating magnetic resonance imaging.

    Additional exclusion criteria for Trauma-exposed healthy controls (TEHC) group:

  9. History of Axis I psychiatric diagnosis (current/past); (e.g., substance use disorder, eating disorder, mood disorders, anxiety disorders, OCD, PTSD).

Sites / Locations

  • NYU Langone HealthRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

PTSD group

Trauma-Exposed Healthy Controls (TEHC)

Arm Description

After the initial screening / baseline assessment visit, Post Traumatic Stress Disorder participants will undergo two Experimental Visits, which included participation in an emotional learning paradigm and an fMRI scan over the course of two consecutive days. Participants will be asked to look at pictures on a computer screen to measure physiological response physiological response (skin conductance response) and brain responses using a functional Magnetic Resonance Imaging (fMRI) machine. These two visits will be scheduled within a month from the baseline assessment visit.

After the initial screening / baseline assessment visit, trauma-exposed healthy participants will undergo two Experimental Visits, which included participation in an emotional learning paradigm and an fMRI scan over the course of two consecutive days. Participants will be asked to look at pictures on a computer screen to measure physiological response physiological response (skin conductance response) and brain responses using a functional Magnetic Resonance Imaging (fMRI) machine. These two visits will be scheduled within a month from the baseline assessment visit.

Outcomes

Primary Outcome Measures

Comparison of Skin Conductance Response (SCR) of PTSD participants and Trauma-Exposed Healthy Controls
Skin Conductance Response will be collected from subjects during the entire course of the experiment, inside or outside of the fMRI scanner, to measure stress/sweat level. SCR is used by many psychological experiments to measure the participants stress/sweat, or level of anxiety in a particular moment, or in response to a specific cue.
Comparison of fMRI data of PTSD participants and Trauma-Exposed Healthy Controls
Participants will undergo a 3T MRI scan during the both experimental. All standard sequences and RF coils which we intend to use at the Center for Brain Imaging are FDA certified.fMRI data will be collected from subjects during the entire course of the 2-day experiment inside the fMRI scanner. fMRI data, including blood-oxygen-level-dependent (BOLD) responses, is used in neuroimaging studies assess neural correlate activations and observe the increase/decrease in activation of a particular brain area in response to a specific cue.

Secondary Outcome Measures

Change in Anxiety
State-Trait Anxiety Inventory STAI (State) The State-Trait Anxiety Inventory (STAI) is a psychological inventory based on a 4-point Likert scale and consists of 40 questions on a self-report basis. The STAI measures two types of anxiety - state anxiety, or anxiety about an event, and trait anxiety, or anxiety level as a personal characteristic.
Change in Emotional Stress tolerance
Distress Tolerance Scale (DTS) is a 15 item self-report measure of emotional distress tolerance. Individuals select on a 1-5 likert scale. (Strongly Disagree, Mildly Disagree, Feel Neutral, Mildly Agree, Strongly Agree) about each of the 16 statements about distress.
Change in shock expectancy
Shock expectancy questionnaire is a self reported questionnaire that measures what they expect to see certain colors and whether they expected to feel shocks in the study.
Ratings of Pleasantness in Conditioned Stimuli and Unconditioned Stimulus
Pleasantness Rating of relief scale measures participants sense of the relief they felt when no shock was given, on a scale from 1 to 5 (1=neutral, 5=extremely pleasant)
Ratings of Unpleasantness in Conditioned Stimuli and Unconditioned Stimulus
Rating of Conditioned Stimuli(CS) and Unconditioned Stimulus (US) Unpleasantness measures participants sense of the unpleasantness they felt when the CS was given, on a scale from 1 to 5 (1=neutral, 5=extremely pleasant)

Full Information

First Posted
February 22, 2021
Last Updated
January 3, 2023
Sponsor
NYU Langone Health
Collaborators
National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT04770584
Brief Title
Fear and Avoidance in PTSD Patients
Official Title
Neural Correlates of Active Avoidance Learning and Their Interactions With Fear Extinction Mechanisms in PTSD Patients
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2021 (Actual)
Primary Completion Date
January 2026 (Anticipated)
Study Completion Date
January 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NYU Langone Health
Collaborators
National Institute of Mental Health (NIMH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this research study is to study how the brain learn to avoid certain stimuli or situations using an experimental paradigm. The big goal is to measure brain responses and subject's feelings and expectations when they are learning to actively avoid experimental stimuli, and how fear extinction learning and monetary cost can change how and when subjects are to avoid.
Detailed Description
This study aims to study the neural correlates of avoidance learning using a recently validated conditioning and active avoidance paradigm (CAAP). The overarching objective is to measure the neural correlates of active avoidance, and how fear extinction learning and monetary cost modulate these avoidance responses. Participants will include trauma-exposed healthy controls (TEHC), and participants with post-traumatic stress disorder (PTSD). Avoidance is common and often hinders the progression and success of extinction-based exposure therapy in PTSD. The data to be gathered in this study will enable us to probe neural mechanisms of avoidance, extinction, and decision-making to avoid or not, in addition to understanding the impact of cost on avoidance decision-making. These data will provide a more integrated platform for the understanding of the mechanisms of avoidance in both trauma-exposed healthy controls and PTSD psychopathology, which has important implications for treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post Traumatic Stress Disorder

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
PTSD group
Arm Type
Other
Arm Description
After the initial screening / baseline assessment visit, Post Traumatic Stress Disorder participants will undergo two Experimental Visits, which included participation in an emotional learning paradigm and an fMRI scan over the course of two consecutive days. Participants will be asked to look at pictures on a computer screen to measure physiological response physiological response (skin conductance response) and brain responses using a functional Magnetic Resonance Imaging (fMRI) machine. These two visits will be scheduled within a month from the baseline assessment visit.
Arm Title
Trauma-Exposed Healthy Controls (TEHC)
Arm Type
Other
Arm Description
After the initial screening / baseline assessment visit, trauma-exposed healthy participants will undergo two Experimental Visits, which included participation in an emotional learning paradigm and an fMRI scan over the course of two consecutive days. Participants will be asked to look at pictures on a computer screen to measure physiological response physiological response (skin conductance response) and brain responses using a functional Magnetic Resonance Imaging (fMRI) machine. These two visits will be scheduled within a month from the baseline assessment visit.
Intervention Type
Other
Intervention Name(s)
Fear Conditioning
Intervention Description
Participants will be administered increasing intensities of mild electric shock via electrodes connected to the foot. New Biopac stimulators that can deliver higher shock intensity, provided participants agreement will be used to assure adequate conditioning levels. Stimulation is measures in milliamps (mA), and each delivered stimulation will be 0.5 seconds long (500 milliseconds). To colored (blue, red, & yellow) light stimuli (CS). The light stimulus is followed by a shock or no shock depending on color (blue & red - shock; yellow - no shock).
Intervention Type
Other
Intervention Name(s)
Avoidance conditioning
Intervention Description
Via button pressing. Only one stimulus-CS (i.e. blue colored light) will enable control over experiencing the shock: the participant can press the button during the first 2 seconds of the light presentation to avoid the shock. CS stays on for 6 seconds after the button is pressed. If the button is pressed, no shock will be administered. After 6 seconds, the light ends and the relief epoch ('good feeling') begins. Pressing the button to the other CS (i.e. red colored light) will not prevent the shock from occurring- the participant will still receive the mild shocked at CS offset (after 6 seconds). The third CS (i.e. yellow light) will serve as a control CS, so while the button is available, pressing it or not is of no consequence.
Intervention Type
Other
Intervention Name(s)
Pavlovian fear extinction learning
Intervention Description
After avoidance conditioning, the CS+ associated with avoidance responding (i.e. blue light) appears with no button to press and no shock is administered.
Intervention Type
Other
Intervention Name(s)
Willingness to pay to avoid shock
Intervention Description
On the next day, participants receive a monetary stipend to use to pay to guarantee that they are not to receive any shocks if they press a button from the CS+. No shocks will be delivered on day 2, regardless of money paid. This and all previously described experimental phases noted above will occur inside of the fMRI scanner.
Primary Outcome Measure Information:
Title
Comparison of Skin Conductance Response (SCR) of PTSD participants and Trauma-Exposed Healthy Controls
Description
Skin Conductance Response will be collected from subjects during the entire course of the experiment, inside or outside of the fMRI scanner, to measure stress/sweat level. SCR is used by many psychological experiments to measure the participants stress/sweat, or level of anxiety in a particular moment, or in response to a specific cue.
Time Frame
Experimental Day 1, Experimental Day 2
Title
Comparison of fMRI data of PTSD participants and Trauma-Exposed Healthy Controls
Description
Participants will undergo a 3T MRI scan during the both experimental. All standard sequences and RF coils which we intend to use at the Center for Brain Imaging are FDA certified.fMRI data will be collected from subjects during the entire course of the 2-day experiment inside the fMRI scanner. fMRI data, including blood-oxygen-level-dependent (BOLD) responses, is used in neuroimaging studies assess neural correlate activations and observe the increase/decrease in activation of a particular brain area in response to a specific cue.
Time Frame
Experimental Day 1, Experimental Day 2
Secondary Outcome Measure Information:
Title
Change in Anxiety
Description
State-Trait Anxiety Inventory STAI (State) The State-Trait Anxiety Inventory (STAI) is a psychological inventory based on a 4-point Likert scale and consists of 40 questions on a self-report basis. The STAI measures two types of anxiety - state anxiety, or anxiety about an event, and trait anxiety, or anxiety level as a personal characteristic.
Time Frame
Experimental Day 1, Experimental Day 2
Title
Change in Emotional Stress tolerance
Description
Distress Tolerance Scale (DTS) is a 15 item self-report measure of emotional distress tolerance. Individuals select on a 1-5 likert scale. (Strongly Disagree, Mildly Disagree, Feel Neutral, Mildly Agree, Strongly Agree) about each of the 16 statements about distress.
Time Frame
Experimental Day 1, Experimental Day 2
Title
Change in shock expectancy
Description
Shock expectancy questionnaire is a self reported questionnaire that measures what they expect to see certain colors and whether they expected to feel shocks in the study.
Time Frame
Experimental Day 1, Experimental Day 2
Title
Ratings of Pleasantness in Conditioned Stimuli and Unconditioned Stimulus
Description
Pleasantness Rating of relief scale measures participants sense of the relief they felt when no shock was given, on a scale from 1 to 5 (1=neutral, 5=extremely pleasant)
Time Frame
Experimental Day 1, Experimental Day 2
Title
Ratings of Unpleasantness in Conditioned Stimuli and Unconditioned Stimulus
Description
Rating of Conditioned Stimuli(CS) and Unconditioned Stimulus (US) Unpleasantness measures participants sense of the unpleasantness they felt when the CS was given, on a scale from 1 to 5 (1=neutral, 5=extremely pleasant)
Time Frame
Experimental Day 1, Experimental Day 2

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18 - 70 years of age Female or Male Inclusion Criteria: PTSD Subjects a. Diagnosis of current PTSD (as determined by CAPS, and primary diagnosis of PTSD as determined by SCID assessment of comorbidity) Inclusion Criteria: Trauma-exposed healthy controls (TEHC) SCID diagnosis consistent with no current or past history of Axis I psychiatric disorders, and no current or past history of PTSD (as determined by the CAPS). History of trauma exposure. Willing and able to provide informed consent. Exclusion Criteria for ALL subjects: History of neurologic disease (e.g. tic disorder) Current suicidal ideation, plan or intent or suicidal behavior in past 6 months based on CSSRS or Self-injurious behavior that involves suicidal intent, requires medical attention, or occurs daily History of seizure or significant head trauma (i.e., extended loss of consciousness, neurological sequelae, or known structural brain lesion) History of the following Axis I psychiatric diagnosis: psychotic disorder, bipolar disorder, current eating disorder, or current or early remission substance abuse disorder. Use of psychotropic medication within 4 weeks prior to study (within 6 weeks for fluoxetine, or other long-lived compounds; within one year for neuroleptics). Current substance use (assessed by urine toxicology; positive urine toxicology screen for any substance, with the exception of THC). Pregnancy (to be ruled out by urine ß-HCG). Metallic implants or devices contraindicating magnetic resonance imaging. Additional exclusion criteria for Trauma-exposed healthy controls (TEHC) group: History of Axis I psychiatric diagnosis (current/past); (e.g., substance use disorder, eating disorder, mood disorders, anxiety disorders, OCD, PTSD).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mohammed Milad, MD
Phone
646-754-7406
Email
Mohammed.milad@nyulangone.org
First Name & Middle Initial & Last Name or Official Title & Degree
Hannah McManus
Phone
646-754-7168
Email
Hannah.Mcmanus@nyulangone.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mohammed Milad
Organizational Affiliation
NYU Langone
Official's Role
Principal Investigator
Facility Information:
Facility Name
NYU Langone Health
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Noor Nassar
Phone
212-404-3850
Email
noor.nassar@nyulangone.org
First Name & Middle Initial & Last Name & Degree
Mohammed R Milad, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
IPD Sharing Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
IPD Sharing Access Criteria
The investigator who proposed to use the data will have access and give upon reasonable request. Requests should be directed to mohammed.milad@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Learn more about this trial

Fear and Avoidance in PTSD Patients

We'll reach out to this number within 24 hrs